{"id":"W4207018755","doi":"10.1016/j.euros.2021.12.007","title":"Efficacy and Safety of First-line Systemic Therapy for Metastatic Renal Cell Carcinoma: A Systematic Review and Network Meta-analysis","year":2022,"lang":"en","type":"review","venue":"European Urology Open Science","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":99,"is_retracted":false,"has_abstract":true,"ca_institutions":"Sinai Health System; Public Health Ontario; University of Toronto; Lunenfeld-Tanenbaum Research Institute; University of Calgary","funders":"","keywords":"Medicine; Axitinib; Oncology; Internal medicine; Ipilimumab; Nivolumab; Discontinuation; Population; Cabozantinib; Clinical endpoint; Pembrolizumab; Renal cell carcinoma; Adverse effect; Progression-free survival; Randomized controlled trial; Clinical trial; Meta-analysis; Immunotherapy; Cancer; Chemotherapy; Sunitinib","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01983833,0.002806912,0.02020828,0.008347173,0.0005597107,0.003090356,0.002377274,0.002073904,0.004532055],"category_scores_gemma":[0.03994974,0.001248735,0.03731414,0.009100337,0.0006708755,0.001919435,0.001592858,0.001759912,0.0003727787],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003518605,"about_ca_system_score_gemma":0.004394163,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.007594922,"about_ca_topic_score_gemma":0.01484334,"domain_scores_codex":[0.9869553,0.007193103,0.002896862,0.001165838,0.001478636,0.0003101843],"domain_scores_gemma":[0.9747524,0.01915614,0.003718447,0.0006112728,0.001496249,0.0002654424],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.001355091,0.00002064621,0.002404741,0.3858653,0.6005873,0.00008957475,0.00005536986,0.0008451986,0.000122463,0.0001437121,0.0004860617,0.008024584],"study_design_scores_gemma":[0.0005050641,0.0001510961,0.002221463,0.02827447,0.9667941,0.00007059481,0.00002852541,0.0003621609,0.00007162779,0.0002373893,0.001263304,0.00002005424],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.004640451,0.9918619,0.001031901,0.0002775523,0.000141638,0.0006024342,0.001053806,0.00003224117,0.0003580323],"genre_scores_gemma":[0.2018544,0.7875953,0.004182673,0.001118239,0.0002775125,0.002941687,0.001564113,0.00004051939,0.0004255353],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.02020828,"threshold_uncertainty_score":0.1049164,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1654302413443574,"score_gpt":0.3639401654332167,"score_spread":0.1985099240888592,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}